Smit JW, Basile P, Prato MK, Detalle L, et al. Phase 1/1b Studies of UCB0599, an Oral Inhibitor of alpha-Synuclein Misfolding, Including a Randomized Study in Parkinson's Disease. Mov Disord 2022 Aug 12. doi: 10.1002/mds.29170.
PMID: 35959805